Abstract
White matter (WM) alterations have been observed in Huntington disease (HD) but their role in the disease-pathophysiology remains unknown. We assessed WM changes in premanifest HD by exploiting ultra-strong-gradient magnetic resonance imaging (MRI). This allowed to separately quantify magnetization transfer ratio (MTR) and hindered and restricted diffusion-weighted signal fractions, and assess how they drove WM microstructure differences between patients and controls. We used tractometry to investigate region-specific alterations across callosal segments with well-characterized early- and late-myelinating axon populations, while brain-wise differences were explored with tract-based cluster analysis (TBCA). Behavioral measures were included to explore disease-associated brain-function relationships. We detected lower MTR in patients' callosal rostrum (tractometry: p =.03; TBCA: p =.03), but higher MTR in their splenium (tractometry: p =.02). Importantly, patients' mutation-size and MTR were positively correlated (all p-values
Author supplied keywords
Cite
CITATION STYLE
Casella, C., Chamberland, M., Laguna, P. L., Parker, G. D., Rosser, A. E., Coulthard, E., … Metzler-Baddeley, C. (2022). Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra-strong gradient MRI. Human Brain Mapping, 43(11), 3439–3460. https://doi.org/10.1002/hbm.25859
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.